Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Moodys
Chubb
Queensland Health
Argus Health
McKinsey
Boehringer Ingelheim
Deloitte
McKesson

Generated: April 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: GLECAPREVIR; PIBRENTASVIR

« Back to Dashboard

GLECAPREVIR; PIBRENTASVIR

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. N 0074-2625-01
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. N 0074-2625-56
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. N 0074-2625-28
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Moodys
McKinsey
Teva
Medtronic
Cantor Fitzgerald
Farmers Insurance
Chubb
Mallinckrodt